$ACAD News Article - Acadia Pharmaceuticals Announces August 4, 2022 Action Date for Resubmitted Supplemental New Drug Application for NUPLAZID (pimavanserin) for the Treatment of Alzheimer's Disease Psychosis
https://marketwirenews.com/news-releases/acad...33280.html